KornblihttAR, UmezawaK, Vibe-PedersenK, BaralleFE.Primary structure of human plasma fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. EMBO J.1985;4:1755–9.
2.
SkorstengaardK, JensenMS, SahlO, PetersenTE, MagnussonS.Purification and a complete primary structures of the heparin-, cell-, and DNA-binding domains of bovine plasma fibronectin. Eur J Biochem.1986;161:441–53.
3.
SchwarzbauerJE, PaulJI, HynesRO.On the origin of species of fibronectin. Proc Natl Acad Sci USA.1985;82:1424–8.
4.
PierschbacherMD, RuoslahtiE.Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the mole-cule. Nature.1984;309:30–3.
5.
HumphriesMJ, KomiyamaA, AkiyamaSK, OldenK, YamadaKM.Identification of two distinct regions of the type III connecting seg-ment of human plasma fibronectin that promote cell type-specific adhe-sion. J Biol Chem.1987;262:6886–92.
6.
WaynerE, Garcia-PardoA, HumphriesM, McDonaldJA, CarterWG.Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J Cell Biol.1989;109:1321–30.
7.
MouldAP, KomiyamaA, YamadaKM, HumphriesMJ.The CS5 peptide is a second site in the IIICS region of fibronectin recognized by the integrin . J Biol Chem.1991;266:3579–85.
8.
McCarthyJB, HagenST, FurchtLT.Human fibronectin contains distinct adhesion and motility promoting domains for metastatic melanoma cells. J Cell Biol.1986;102:179–88.
9.
McCarthyJB, SkubitzPN, PalmSL, FurchtLT.Metastasis inhibi-tion of different tumor types by purified laminin fragments and a heparin-binding fragment of fibronectin. J Natl Cancer Inst.1988;80:108–16.
10.
FujitaH, MohriH, KanamoriH, IwamatsuA, OkuboT.Binding site in human plasma fibronectin to H1-60 cells localizes in the C-termi-nal heparin-binding region independently of RGD and CS1. Exp Cell Res.1995;217:484–9.
11.
McCarthyJB, ChelbergMK, MickelsonDJ, FurchtLT.Localization and chemical synthesis of fibronectin peptides with melanoma adhesion and heparin binding activities. Biochemistry.1988;27:1380–8.
12.
MugnaiG, LewandowskaK, CarnemollaB, ZardiL, CulpLA.Modulation of matrix adhesive responses of human neuroblastoma cells by neighboring sequence in the fibronectin. J Cell Biol.1988;106:931–43.
13.
MouldAP, HumphriesMJ.Identification of a novel recognition sequence for the integrin in the COOH-terminal heparin-binding domain of fibronectin. EMBO J.1991;10:4089–99.
14.
KiefferN, FitzgeraldLA, WolfD, ChereshDA, PhillipsDR.Adhesive properties of the integrins: comparison of GPIIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells. J Cell Biol.1991;113:451–61.
15.
PhillipsDR, CharoIF, ScarboroughRM.GPIIb-IIIa: the respon-sive integrin. Cell.1991;65:359–62.
16.
BrassLF, ShattilSJ, KunickiTJ, BennettJS.Effect of calcium on the stability of the platelet membrane glycoprotein IIb-IIIa complex. J Biol Chem.1985;260:7875–81.
17.
PidardD, DidryD, KunickiTJ, NurdenAT.Temperature-depen-dent effects of EDTA on the membrane glycoprotein IIb-IIIa complex and platelet aggregability. Blood.1986;67:604–11.
18.
PetersenTE, SkorstengaardK.Fibronectins. In: McDonaghJ, editor. Hematology. New York: Dekker; 1985:7–30.
19.
YamadaKM, KennedyDW.Fibroblast cellular and plasma fibronectins are similar but not identical. J Cell Biol.1979;80:492–8.
20.
TamkunJW, SchwarzbauerJE, HynesRO.A single rat fibronectin gene generates three different mRNAs by alternative splicing of a complex exon. Proc Natl Acad Sci USA.1984;81:5140–4.
21.
KornblihttAR, Vibe-PedersenK, BaralleFE.Human fibronectin: molecular cloning evidence for two mRNA species differing by an internal segment coding for a structural domain. EMBO J.1984;3:221–6.
22.
SchwarzbauerJE, TamkunJW, LemischkaIR, HynesRO.Three different fibronectin mRNAs arise by alternative splicing within the cod-ing region. Cell.1983;35:421–31.
23.
PaulJI, SchwarzbauerJE, TamkunJW, HynesRO.Cell-type-specific fibronectin subunits generated by alternative splicing. J Biol Chem.1986;26:12258–65.
24.
Vibe-PedersenK, MagnussonS, BaralleFE.Donor and acceptor spliced signals within an exon of the human fibronectin gene: a new type of differential splicing. FEBS Lett.1986;207:287–91.
25.
SchwarzbauerJE, PatelRS, FondaD, HynesRO.Multiple sites of alternative splicing of the rat fibronectin gene transcript. EMBO J.1987;6:2573–80.
26.
ZardiL, CarnemollaB, SiriA, PetersenTE, PaolellaG, SebastioG, BaralleFE.Transformed human cells produce a new fibronectin iso-form by preferential alternative splicing of a previously unobserved exon. EMBO J.1987;6:2337–42.
27.
Vibe-PedersenK, KornblihttAR, BaralleFE.Expression of a human -globulin/fibronectin gene hybrid generates two mRNAs by alternative splicing. EMBO J.1984;3:2511–6.
28.
XiaP, CulpLA.Adhesion activity in fibronectin's alternatively spliced domain EDa (EIIIA) and its neighboring type III repeats: onco-gene-dependent regulation. Exp Cell Res.1994;213:253–63.
29.
BernardMP, KolbeM, WeilD, ChuM-L. Human cellular fibronectin: comparison of the carboxyl-terminal portion with rat identi-fies primary structural domains separated by hypervariable regions. Biochemistry.1985;24:2698–704.
30.
HynesRO.Molecular biology of fibronectin. Annu Rev Cell Biol.1985;1:67–90.
31.
VossB, AllahS, RauterbergJ, UllrichK, GieselmannV, Von FiguraK.Primary cultures of rat hepatocytes synthesize fibronectin. Biochem Biophys Res Commun.1979;90:1348–54.
32.
MacarakEJ, KirbyE, KirkT, KefalidesNA.Synthesis of cold-insoluble globulin by cultured calf endothelial cells. Proc Natl Acad Sci USA.1978;75:3277.
33.
VilligerB, KellyDG, EnglemanW, KuhnC, McDonaldJA.Human alveolar macrophage fibronectin-synthesis, secretion, and ultra-structural localization during gelatin-coated latex particle binding. J Cell Biol.1981;90:711–20.
34.
YamadaKM.Cell surface interactions with extracellular materi-als. Ann Rev Biochem.1983;52:761–99.
35.
PetersenTE, ThogersenHC, SkorstengaardK, Vobe-PetersenK, SahlP, Sottrup-JensenL, MagnussonS.Partial primary structure of bovine plasma fibronectin: three types of internal homology. Proc Natl Acad Sci USA.1983;80:137–41.
36.
SekiguchiK, FukudaM, HakomoriS.Domain structure of ham-ster plasma fibronectin: isolation and characterization of four functional-ly distinct domains and their unequal distribution between two subunit polypeptides. J Biol Chem.1981;256:6452–62.
37.
RuoslahtiE, HaymanEG.Two activities with different charac-teristics in fibronectin. FEBS Lett.1979;97:221–4.
38.
MosherDF, SchadPE, VannJM.Cross-linking of collagen and fibronectin by factor XIIIa: localization of participating glutaminyl residues to a tryptic fragment of fibronectin. J Biol Chem.1980;255:1181–8.
39.
ZardiL, SiriA, CanemollaB, SantiL, GardnerWD, HochSO.Fibronectin: a chromatin-associated protein?Cell.1979;18:649–57.
40.
HautanenA, Keski-OjaJ.Affinity of myeloma IgG proteins for fibronectin. Clin Exp Immunol.1983;53:233–8.
41.
LahavJ, SchwartzMA, HynesRO.Analysis of platelet adhesion using a radioactive chemical crosslinking reagent: interaction of throm-bospondin with fibronectin and collagen. Cell.1982;31:253–62.
42.
ProctorRA.Fibronectin: a brief overview of its structure, func-tion, and physiology. Reviews of Infectious Diseases.1987;9(4 Suppl):317–21.
43.
SalonenE-M, SakselaO, VartioT, VaheriA, NielsenLS, ZueuthenJ.Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin. J Biol Chem.1985;260:12302–7.
44.
HomandbergGA, EricksonJW.Model of fibronectin tertiary structure based on studies of interactions between fragments. Biochemistry.1986;25:6917–1925.
45.
BalianG, ClickEM, BornsteinP.Localization of collagen-bind-ing domain in fibronectin. J Biol Chem.1980;255:3234–6.
46.
RuoslahtiE, PierschbacherMD.Arg-Gly-Asp: a versatile cell recognition signal. Cell.1986;44:517–8.
47.
PierschbacherMD, RuoslahtiE.Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. Proc Natl Acad Sci USA.1984;81:5985–8.
48.
AkiyamaSK, YamadaKM.Synthetic peptides competitively inhibit both direct binding to fibroblasts and functional biological assays for the purified cell-binding domain of fibronectin. J Biol Chem.1985;260:10402–5.
49.
HaymanEG, PierschbacherMD, RuoslahtiE.Detachment of cells from culture substrate by soluble fibronectin peptides. J Cell Biol.1985;100:1948–54.
50.
ObaraM, KangMS, YamadaKM.Site-directed mutagenesis of the cell-binding domain of human fibronectin: separable, synergistic sites mediate adhesive function. Cell.1988;53:649–57.
51.
AkiyamaSK, HasegawaE, HasegawaT, YamadaKM.The interaction of fibronectin fragments with fibroblastic cells. J Biol Chem.1985;260:13256–60.
52.
StreeterHB, ReesDA.Fibroblast adhesion to RGDS shows novel features compared with fibronectin. J Cell Biol.1987;105:507–15.
53.
AotaS, NagaiT, YamadaKM.Characterization of regions of fibronectin besides the Arginine-Glycine-Aspartic acid sequence required for adhesive function of the cell-binding domain using site-directed mutagenesis. J Biol Chem.1991;266:15938–43.
54.
NagaiT, YamakawaN, AotaS, YamadaSS, AkiyamaSK, OldenK, YamadaKM.Monoclonal antibody characterization of two distinct sites required for function of the central cell-binding domain of fibronectin in cell adhesion, cell migration, and matrix assembly. J Cell Biol.1991;114:1295–305.
55.
AotaS, NomizuM, YamadaKM.The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive func-tion. J Biol Chem.1994;269:24756–61.
56.
HoudijkWPM, SakariassenKS, NievelsteinPFEM, SixmaJJ.Role of factor VIII-von Willebrand factor and fibronetin in the interac-tion of platelets in flowing blood with monomeric and fibrillar human collage type I and III. J Clin Invest.1985;75:531–40.
57.
PariseLV, PhillipsDR.Fibronectin-binding properties of the purified platelet glycoprotein IIb-IIIa complex. J Biol Chem.1986;261:14011–7.
HedmanK, JohannsonS, VartioT, KjellenL, VahreriA, HookM.Structure of the pericellular matrix: association of heparin and chon-droitin sulfates with fibronectin-collagen fibers. Cell.1982;28:663–71.
HayashiM, YamadaKM.Divalent cation modulation of fibronectin binding to heparin and DNA. J Biol Chem.1982;257:5263–7.
62.
RuoslahtiE, HaymanEG, EngvallE, CothranWC, ButlerWT.Alignment of biologically active domains in the fibronectin molecule. J Biol Chem.1981;256:7277–81.
63.
InghamKC, BrewSA, MiglioriniM.An unusual heparin-bind-ing peptide from the carboxy-terminal hep-2 region of fibronectin. Arch Biochem Biophys.1994;314:242–6.
64.
WoodsA, CouchmanJR, JohanssonS, HookM.Adhesion and cytoskeletal organization of fibroblasts in response to fibronetin frag-ments. EMBO J.1986;5:665–70.
65.
RapaegerA, JalkanenM, BernfieldM.Integral membrane pro-teoglycans as matrix receptors: role in cytoskeleton and matrix assembly at the epithelial cell surface. In: WightTN, MechamRP, editors. Biology of proteoglycans. Florida: Academic; 1987:129–54.
66.
VallenEA, EldridgeKA, CulpLA.Heparan sulfate proteogly-cans in the substratum adhesion sites of human neuroblastoma cells: modulation of affinity binding to fibronectin. J Cell Physiol.1988;135:200–12.
67.
SaundersS, BernfieldM.Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor for interstitial matrix. J Cell Biol.1988;106:423–30.
68.
HaugenPK, LetourneauPC, DrakeSL, FurchtLT, McCarthyJB.A cell-surface heparan sulfate proteoglycan mediates neural cell adhe-sion and spreading on a defined sequence from the C-terminal cell and heparin binding domain of fibronectin, FN-C/HII. J Neurosci.1992;12:2597–608.
69.
LewandowskaK, ChoiHU, RosenbergLC, ZardiL, CulpLA.Fibronectin-mediated adhesion of fibroblasts: inhibition by dermatan sulfate proteoglycan and evidence for a cryptic glycosaminoglycan-bind-ing domain. J Cell Biol.1987;105:1443–54.
70.
McCarthyJB, SkubitzAPN, ZhaoQ, YiX-y, MickelsonDJ, KleinDJ, FurchtLT.RGD-independent cell adhesion to the carboxy-ter-minal heparin-binding fragment of fibronectin involves heparin-depen-dent and -independent activities. J Cell Biol.1990;110:777–87.
IidaJ, SkubitzAPN, FurchtLT, WaynerEA, McCarthyJB.Coordinate role for cell surface chondroitin sulfate proteoglycan and integrin in mediating melanoma cell adhesion to fibronectin. J Cell Biol.1992;118:431–44.
73.
Sanchez-AparicioP, FerreiraOC, Garcia-PardoA. recogni-tion of the Hep II domain of fibronectin is constitutive on some hemo-poietic cells but requires activation on others. J Immunol.1993;150:3506–14.
74.
JalkanenS, BargatzeR, HerronLR, ButcherEC.A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol.1986;16:1195–202.
75.
PickerLJ, de los ToyosT, TelenMJ, HaynesB, ButcherEC.Monoclonal antibodies against the CD44 (in(Leu)-related p80), and Pgp-1 antigens in man recognize the Hermes class of lymphocyte homing receptors. J Immunol.1989;142:2046–51.
76.
PickerLJ, NakacheM, ButcherEC.Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol.1989;109:927–38.
77.
JalkanenS, JalkanenM.Lymphocyte CD44 binds to the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol.1992;116:817–25.
MohriH, TanabeJ, KatohK, OkuboT.Identification of specific binding site to platelet membrane glycoprotein IIb/IIIa located in the C-terminal heparin-binding domain of human plasma fibronectin. J Biol Chem.1996;271:15724–8.
80.
HumphriesMJ, AkiyamaSK, KomoriyaA, OldenK, YamadaKM.Identification of alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion. J Cell Biol.1986;103:2637–47.
81.
Garcia-PardoA, WaynerEA, CarterWG, FerreiraOC.Human B lymphocytes define an alternative mechanism of adhesion to fibronectin. The interaction of the integrin with the LHGPEILDVST sequence of the type III connecting segment is sufficient to promote cell attach-ment. J Immunol.1990;144:3361–6.
82.
FerriraOC, Garcia-PardoA, BiancoC.Specific binding of the human monocytic cell line U937 to the alternatively spliced connecting segment (IIICS) of fibronectin. J Exp Med.1990;171:351–6.
83.
DurfourS, DubandJL, HumphriesM, ObaraM, YamadaK, ThieryJP.Attachment, spreading, and locomotion of avian neural crest cells are mediated by multiple adhesion sites on fibronectin molecules. EMBO J.1988;7:2661–71.
84.
HumphriesMJ, AkiyamaSK, KomoriyaA, OldenK, YamadaKM.Neurite extension of chicken peripheral nervous system neurons on fibronectin: relative importance of specific adhesion sites in the central cell-binding domain and the alternatively spliced type III connecting segment. J Cell Biol.1988;106:1289–97.
85.
HershbergerRP, CulpLA.Cell-type-specific expression of alter-natively spliced human fibronectin IIICS mRNA. Mol Cell Biol.1990;10:662–71.
86.
SekiguchiK, KlosAM, KurachiK, YoshitakeS, HakomoriS.Human liver fibronectin complementary DNAs: identification of two different messenger RNAs possibly encoding the and subunits of plasma fibronectin. Biochemistry.1986;25:4936–41.
87.
WaynerEA, KovachNL.Activation-dependent recognition by hematopoietic cells of the LDV sequence in the V region of fibronectin. J Cell Biol.1992;116:489–97.
88.
HormannH, SeidlM.Affinity chromatography on immobilized fibrin monomer III; the fibrin affinity center of fibronectin. Journal of Physiological Chemistry.1980;361:1449–52.
89.
McKeown-LongoPJ, MosherDF.Interaction of the 70,000-mol-wt amino-terminal fragment of fibronectin with the matrix-assembly receptor of fibroblasts. J Cell Biol.1985;100:364–74.
90.
QuadeBJ, McDonaldJA.Fibronectin's amino-terminal matrix assembly site is located within the 29-kd amino-terminal domain con-taining five type I repeats. J Biol Chem.1988;263:19602–9.
91.
SchwarzbauerJE.Identification of the fibronectin sequences required for assembly of a fibrillar matrix. J Cell Biol.1991;113:1463–73.
92.
ScottileJ, SchwarzbauerJ, SelegueJ, MosherDF.Five type I modules of fibronectin form a functional unit that binds to fibroblasts and Staphylococcus aureus. J Biol Chem.1991;266:12840–3.
93.
DzambaBJ, BultmannH, AkiyamaSK, PeterDM.Substrate-specific binding of the amino terminus of fibronectin to an integrin com-plex in focal adhesions. J Biol Chem.1994;269:19646–52.
94.
ProctorDF, MosherDF.Binding of factor XIIIa-mediated cross-linking of a 27-kilodalton fragment of fibronectin to Staphylococcus aureus. Science.1980;209:927–9.
95.
HynesRO.Integrins: versatility, modulation, and signaling in cell adhesion. Cell.1992;69:11–25.
96.
RuoslahtiE.Integrins. J Clin Invest.1991;87:1–5.
97.
AlbeldaSM, BuckCA.Integrins and other cell adhesion mole-cules. FASEB J.1990;4:2868–80.
98.
HemlerME.VLA proteins in the integrin family: structures, functions and their role on leukocytes. Annu Rev Immunol.1990;8:365–400.
99.
SpringerTA.The sensation and regulation of interactions with the extracellular environment: the cell biology of lymphocyte adhesion receptors. Annu Rev Cell Biol.1990;6:359–402.
MohriH, OhkuboT.Effect of cyclic Arg-Gly-Asp-containing peptide of fibronectin binding to activated platelets: role of fibronectin on platelet aggregation. Peptides.1993;14:861–5.
102.
GinsbergMH, LoftusJC, PlowEF.Cytoadesins, integrins, and platelets. Thromb Haemost.1988;59:1–6.
103.
D'SouzaSE, GinsbergMH, BurkeTA, LamSC-T, PlowEF.The ligand binding site of platelet integrin receptor GPIIb-IIIa is proxi-mal to the subunit. J Biol Chem.1990;265:3440–6.
104.
StaatzWD, FokKF, ZutterMM, AdamsSP, RodriguezBA, SantoroSA.Identification of a tetrapeptide recognition sequence for the α2β1 integrin in collagen. J Biol Chem.1991;266:243–54.
105.
LoikeJD, SodeikB, CaoL, LeuconaS, WeitzJI, DetmersPA, WrightSD, SilversteinSC.CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A chain of fibrinogen. Proc Natl Acad Sci USA.1991;88:1044–8.
106.
HallDE, ReichardtLF, CrowleyE, HolleyB, MoezziH, SonnenbergA, DamskyCH.The integrin heterodimers mediate cell attachment to distinct sites on laminin. J Cell Biol.1990;110:2175–84.
107.
DiamondMS, StauntonDE, MarlinSD, SpringerTA.Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell.1991;65:961–71.
108.
StautonDE, DustinML, EricksonHP, SpringerTA.The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell.1990;61:243–54.
ShimizuY, Van SeventerGA, HorganKJ, ShawS.Regulated expression and binding of three VLA () integrin receptors on T cells. Nature.1990;345:250–3.
111.
GrinnelF.Fibronectin and wound healing. J Cell Biol.1984;26:107–16.
112.
YamadaKM, AkiyamaSK, HasegawaT, HasegawaE, HumphriesMJ, KennedyDW, NagataK, UrushiharaH, OldenK, ChenW-T. Recent advances in research on fibronectin and other cell attach-ment proteins. J Cell Biochem.1985;28:79–97.
113.
RuoslahtiE, EngvallE, HaymanEG.Fibronectin: current con-cepts of its structure and functions. Collagen Relative Research.1981;1:95–128.
114.
PlantefaberLC, HynesRO.Changes in integrin receptors on oncogenically transformed cells. Cell.1989;56:281–90.
115.
GiancottiFG, RuoslahtiE.Elevated levels of the fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell.1990;60:849–59.
116.
HumphriesMJ, OldenK, YamadaKM.A synthetic peptide from fibronectin inhibits experimental metastasis in a murine melanoma cells. Science.1986;233:467–70.
117.
GehlsenKR, ArgravesWS, PierschbacherMD, RuoslahtiE.Inhibition of in vitro tumor invasion by Arg-Gly-Asp-containing syn-thetic peptides. J Cell Biol.1988;106:925–30.
118.
WerbZ, TremblePM, BehrendtsenO, CrowleyE, DamskyCH.Signal induction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol.1989;109:877–89.
119.
VuoriK, RuoslahtiE.Activation of protein kinase C precedes integrin-mediated cell spreading on fibronectin. J Biol Chem.1933;268:21459–62.
RoseGD, SanesJR, LaChanceR, CunninghamJM, RomanJ, DeanDC.Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell.1992;69:1107–19.
126.
WaiteKA, MungaiG, CulpLA.A second cell-binding domain on fibronectin (RGDS-independent) for neurite extension of human neu-roblastoma cells. Exp Cell Res.1987;169:311–27.
127.
BeythRJ, CulpLA.Complementary adhesive responses of human skin fibroblasts to the cell-binding domain of fibronectin and the heparan sulfate-binding protein, platelet factor-4. Exp Cell Res.1984;155:537–48.
128.
GuanJL, HynesRO.Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor . Cell.1990;60:53–61.
129.
MouldAP, WheldonLA, KomoriyaA, WaynerEA, YamadaKM, HumphriesMJ.Affinity chromatographic isolation of the melanoma adhesion receptor for the IIICS region of fibronectin recog-nized by the integrin . J Biol Chem.1990;265:4020–4.
130.
LiottaLA, RaoCV, BaeskySH.Tumor invasion and the extra-cellular matrix. Lab Invest.1983;49:636–49.
131.
McCarthyJB, BasaraML, PalmSL, SasDF, FurchtLT.The role of cell adhesion proteins-laminin and fibronectin-in the move-ment of malignant and metastatic cells. Cancer Metastasis Rev.1985;4:125–52.
132.
BarskySH, RaoCN, WilliamsJE, LiottaLA.Laminin molecu-lar domains which alter metastasis in a murine model. J Clin Invest.1984;42:2265–9.
133.
WeissHJ, HawigerJ, RuggeriZM, TurittoVT, ThiagarajanP, HoffmanT.Fibrinogen-independent platelet adhesion and thrombus for-mation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J Clin Invest.1989;83:288–97.
134.
IkedaY, HandaM, KawanoK, KamataT, MurataM, ArakiY, AndoH, KawaiY, WatanabeK, ItagakiI, SakaiK, RuggeriZM.The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest.1991;87;1234–40.
135.
PariseLV, PhillipsDR.Reconstitution of the purified platelet fibrinogen receptor. Fibrinogen binding properties of the glycoprotein IIb-IIIa complex. J Biol Chem.1985;260;1234–40.
136.
PlowEF, GinsbergMH, MarguerieGA.Expression and func-tion of adhesive proteins on the platelet surface, In: PhillipsDR, ShumanMA, editors. Biochemistry of platelets. San Diego: Academic Press; 1986:226–56.
137.
FujimotoT, CharaS, HawigerJ.Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets metagenomics. J Clin Invest.1982;69:1212–22.
138.
RuggeriZM, DeMarcoL, GattiL, BaderR, MontgomeryRR.Platelets have more than one binding sites for von Willebrand factor. J Clin Invest.1983;72:1–12.
139.
DeMarcoL, GirolamiA, ZimmermanTS, RuggeriZM.Von Willebrand factor interaction with glycoprotein IIb-IIIa complex. Its role in platelet function as demonstrated in patients with congenital afibrino-genemia. J Clin Invest.1986;77:1272–7.
140.
WeissHJ, TurittoVT, BaumgartnerHR.Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoprotein IIb-IIIa, Ib and storage granules. Blood.1986;67:322–30.
141.
LawrenceJB, GralnickHR.Monoclonal antibodies to the glycoprotein IIb-IIa epitopes involved in adhesive protein binding: effects of platelet spreading and ultrastructure on human arterial subendothelium. J Lab Clin Med.1987;109:495–503.
142.
PlowEF, GinsbergMH.Specific and saturable binding to plasma fibronectin to thrombin-stimulated human platelets. J Biol Chem.1981;256:9477–82.
143.
PytelaR, PierschbacherMD, GinsbergMH, PlowEF, RuoslahtiE.Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp specific adhesion receptors. Science.1986;231:1559–62.
144.
PlowEF, SroujiAH, MeyerD, MarguerieG, GinsbergMH.Evidence that three adhesive proteins interact with a common recogni-tion site on activated platelets. J Biol Chem.1984;259:5388–91.
145.
GardnerJM, HynesRO.Interaction of fibronectin with its receptor on platelets metagenomics. Cell.1985;42:439–48.
146.
PlowEF, McEverRP, CollerBS, WoodsVL, MarguerieGA, GinsbergMH.Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor, and thrombospondin on thrombin-stimulated platelets metagenomics. Blood.1985;66:724–7.
147.
GinsbergMH, PierschbacherMD, RuoslahtiE, MarguerieGA, PlowEF.Inhibition of fibronectin binding to platelets by proteolytic fragments and synthetic peptides which support fibroblast adhesion metagenomics. J Biol Chem.1985;260:3931–6.
148.
GartnerTK, BennettJS.The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets metagenomics. J Biol Chem.1985;260:11891–4.
149.
PiotrowiczRS, YamadaKM, KunickiTJ.Glycoprotein Ic-Ila functions as an activation-dependent fibronectin receptor on platelets. J Cell Biol.1988;106:1359–64.
150.
DixitVM, HaverstickDM, O'Rouke. Inhibition of platelet aggregation by a monoclonal antibody against human fibronectin. Proc Natl Acad Sci USA.1982;82:3844–8.
151.
BowditchRD, MariharanM, TomiyamaEF, PlowEF, YamadaKM, GinsbergMH.Identification of a novel integrin binding site in fibronectin. Differential utilization by β3 intergrins. J Biol Chem.1994;269:10856–63.
152.
MohriH, TanabeJ, KatohK, OkuboT.Synthetic peptides demonstrate RGD-independent platelet glycoprotein IIb/IIIa recognition site in cell binding domain of human fibronectin. Peptides.1995;16:263–8.
153.
LamSC-T, PlowEF, SmithMA, AndrieuxA, RyckwaertJ-J, MarguerieG, GinsbergMH.Evidence that Arginyl-Glycyl-Aspartate peptides and fibrinogen γ chain peptides share a common binding site on platelets. J Biol Chem.1987;262:947–50.
154.
SantoroS, LawingWJ.Competition for related but nonidentical binding sites on the glycoprotein IIb-IIIa complex by peptides derived from platelet adhesive proteins. Cell.1987;48:867–73.
155.
MohriH, OhkuboT.The role of the RGD peptides and the chain peptide of fibrinogen on fibrinogen binding to activated platelets. Peptides.1993;14:353–7.
156.
D'SouzaSE, GinsbergMH, BurkeTA, LamSC-T, PlowEF.Localization of an Arg-Gly-Asp recognition site within an integrin adhe-sion receptor. Science.1988;242:91–3.
157.
SteinerB, TrzeciakA, PfenningerG, KounsWC.Peptides derived from a sequence within β3 integrin bind to platelet αIIbβ1 (GPIIb-IIIa) and inhibit ligand binding. J Biol Chem.1993;268:6870–3.
